{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T04:54:32Z","timestamp":1784350472639,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1124\/molpharm.122.000606","type":"journal-article","created":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T07:25:55Z","timestamp":1669965955000},"page":"188-198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Gait Abnormalities and Aberrant D2 Receptor Expression and Signaling in Mice Carrying the Human Pathogenic Mutation DRD2"],"prefix":"10.1016","volume":"103","author":[{"given":"Dayana","family":"Rodriguez-Contreras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph J.","family":"Lebowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lev M.","family":"Fedorov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naeem","family":"Asad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M.","family":"Dore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7350-6323","authenticated-orcid":false,"given":"Tamara J.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0109-7345","authenticated-orcid":false,"given":"Kim A.","family":"Neve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/molpharm.122.000606_bib1","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0026-895X(24)26497-X","article-title":"The effect of mutations in the DRY motif on the constitutive activity and structural instability of the histamine H(2) receptor","volume":"57","author":"Alewijnse","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1124\/molpharm.122.000606_bib2","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1021\/acschemneuro.9b00675","article-title":"Photoactivatable dopamine and sulpiride to explore the function of dopaminergic neurons and circuits","volume":"11","author":"Asad","year":"2020","journal-title":"ACS Chem Neurosci"},{"key":"10.1124\/molpharm.122.000606_bib3","doi-asserted-by":"crossref","first-page":"29171","DOI":"10.1074\/jbc.M103747200","article-title":"Activation of the \u03b2 2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6","volume":"276","author":"Ballesteros","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/molpharm.122.000606_bib4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/B978-0-444-63916-5.00014-8","article-title":"Dystonia","volume":"159","author":"Barbosa","year":"2018","journal-title":"Handb Clin Neurol"},{"key":"10.1124\/molpharm.122.000606_bib5","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/pr.110.002642","article-title":"The physiology, signaling, and pharmacology of dopamine receptors","volume":"63","author":"Beaulieu","year":"2011","journal-title":"Pharmacol Rev"},{"key":"10.1124\/molpharm.122.000606_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.parkreldis.2017.05.004","article-title":"ADCY5-related movement disorders: Frequency, disease course and phenotypic variability in a cohort of paediatric patients","volume":"41","author":"Carecchio","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1124\/molpharm.122.000606_bib7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/B978-0-444-63425-2.00010-6","article-title":"The role of dopamine in Huntington\u2019s disease","volume":"211","author":"Cepeda","year":"2014","journal-title":"Prog Brain Res"},{"key":"10.1124\/molpharm.122.000606_bib8","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1001\/archneurol.2012.54","article-title":"Autosomal dominant familial dyskinesia and facial myokymia: single exome sequencing identifies a mutation in adenylyl cyclase 5","volume":"69","author":"Chen","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1124\/molpharm.122.000606_bib9","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/ana.24119","article-title":"Gain-of-function ADCY5 mutations in familial dyskinesia with facial myokymia","volume":"75","author":"Chen","year":"2014","journal-title":"Ann Neurol"},{"issue":"W1","key":"10.1124\/molpharm.122.000606_bib10","doi-asserted-by":"crossref","first-page":"W242","DOI":"10.1093\/nar\/gky354","article-title":"CRISPOR: intuitive guide selection for CRISPR\/Cas9 genome editing experiments and screens","volume":"46","author":"Concordet","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/molpharm.122.000606_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109465","article-title":"The residence of synaptically released dopamine on D2 autoreceptors","volume":"36","author":"Condon","year":"2021","journal-title":"Cell Rep"},{"key":"10.1124\/molpharm.122.000606_bib12","doi-asserted-by":"crossref","first-page":"11550","DOI":"10.1523\/JNEUROSCI.3307-09.2009","article-title":"Striatal expression of a calmodulin fragment improved motor function, weight loss, and neuropathology in the R6\/2 mouse model of Huntington\u2019s disease","volume":"29","author":"Dai","year":"2009","journal-title":"J Neurosci"},{"key":"10.1124\/molpharm.122.000606_bib13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nbt.3437","article-title":"Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9","volume":"34","author":"Doench","year":"2016","journal-title":"Nat Biotechnol"},{"key":"10.1124\/molpharm.122.000606_bib14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bcp.2019.02.005","article-title":"Functional characterization of AC5 gain-of-function variants: Impact on the molecular basis of ADCY5-related dyskinesia","volume":"163","author":"Doyle","year":"2019","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/molpharm.122.000606_bib15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.nbd.2018.05.005","article-title":"GNAO1-associated movement disorder","volume":"116","author":"Feng","year":"2018","journal-title":"Neurobiol Dis"},{"key":"10.1124\/molpharm.122.000606_bib16","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/ana.98","article-title":"Familial dyskinesia and facial myokymia (FDFM): a novel movement disorder","volume":"49","author":"Fernandez","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1124\/molpharm.122.000606_bib17","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1074\/jbc.272.5.2587","article-title":"Structural instability of a constitutively active G protein-coupled receptor. Agonist-independent activation due to conformational flexibility","volume":"272","author":"Gether","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1124\/molpharm.122.000606_bib18","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1016\/j.neuron.2021.08.012","article-title":"Cocaine shifts dopamine D2 receptor sensitivity to gate conditioned behaviors","volume":"109","author":"Gong","year":"2021","journal-title":"Neuron"},{"key":"10.1124\/molpharm.122.000606_bib19","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1073\/pnas.051632598","article-title":"Most central nervous system D2 dopamine receptors are coupled to their effectors by Go","volume":"98","author":"Jiang","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/molpharm.122.000606_bib20","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1124\/molpharm.122.000606_bib21","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1212\/WNL.35.10.1450","article-title":"The gait abnormality of Huntington\u2019s disease","volume":"35","author":"Koller","year":"1985","journal-title":"Neurology"},{"key":"10.1124\/molpharm.122.000606_bib22","doi-asserted-by":"crossref","first-page":"7931","DOI":"10.1523\/JNEUROSCI.22-18-07931.2002","article-title":"Impaired D2 dopamine receptor function in mice lacking type 5 adenylyl cyclase","volume":"22","author":"Lee","year":"2002","journal-title":"J Neurosci"},{"key":"10.1124\/molpharm.122.000606_bib23","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.11102","article-title":"A dystonia-like movement disorder with brain and spinal neuronal defects is caused by mutation of the mouse laminin \u03b21 subunit, Lamb1","volume":"4","author":"Liu","year":"2015","journal-title":"eLife"},{"issue":"6 Suppl 1","key":"10.1124\/molpharm.122.000606_bib24","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/NRL.0b013e3182396688","article-title":"Dopamine receptors, motor responses, and dopaminergic agonists","volume":"17","author":"Luquin-Piudo","year":"2011","journal-title":"Neurologist"},{"key":"10.1124\/molpharm.122.000606_bib25","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.neuron.2018.03.038","article-title":"Regional heterogeneity of D2-receptor signaling in the dorsal striatum and nucleus accumbens","volume":"98","author":"Marcott","year":"2018","journal-title":"Neuron"},{"key":"10.1124\/molpharm.122.000606_bib26","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/mds.28634","article-title":"Childhood-onset chorea caused by a recurrent de novo DRD2 variant","volume":"36","author":"Mencacci","year":"2021","journal-title":"Mov Disord"},{"key":"10.1124\/molpharm.122.000606_bib27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0026-895X(24)26398-7","article-title":"Mutation of a highly conserved aspartic acid in the \u03b22 adrenergic receptor: constitutive activation, structural instability, and conformational rearrangement of transmembrane segment 6","volume":"56","author":"Rasmussen","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1124\/molpharm.122.000606_bib28","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1021\/acschemneuro.0c00712","article-title":"Signaling-biased and constitutively active dopamine D2 receptor variant","volume":"12","author":"Rodriguez-Contreras","year":"2021","journal-title":"ACS Chem Neurosci"},{"key":"10.1124\/molpharm.122.000606_bib29","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41598-017-18826-5","article-title":"Electroporation of mice zygotes with dual guide RNA\/Cas9 complexes for simple and efficient cloning-free genome editing","volume":"8","author":"Teixeira","year":"2018","journal-title":"Sci Rep"},{"key":"10.1124\/molpharm.122.000606_bib30","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2144\/00291bm09","article-title":"Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT)","volume":"29","author":"Truett","year":"2000","journal-title":"Biotechniques"},{"key":"10.1124\/molpharm.122.000606_bib31","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3390\/biomedicines9080879","article-title":"Candidate genes encoding dopamine receptors as predictors of the risk of antipsychotic-induced parkinsonism and tardive dyskinesia in schizophrenic patients","volume":"9","author":"Vaiman","year":"2021","journal-title":"Biomedicines"},{"key":"10.1124\/molpharm.122.000606_bib32","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/mds.28385","article-title":"A gain-of-function variant in dopamine D2 receptor and progressive chorea and dystonia phenotype","volume":"36","author":"van der Weijden","year":"2021","journal-title":"Mov Disord"},{"key":"10.1124\/molpharm.122.000606_bib33","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/mds.28635","article-title":"Reply to: \"Childhood Onset Chorea Caused by a Recurrent De Novo DRD2 Variant\"","volume":"36","author":"van der Weijden","year":"2021","journal-title":"Mov Disord"},{"key":"10.1124\/molpharm.122.000606_bib34","doi-asserted-by":"crossref","first-page":"e492","DOI":"10.1038\/tp.2014.131","article-title":"N-Acetylcysteine improves mitochondrial function and ameliorates behavioral deficits in the R6\/1 mouse model of Huntington\u2019s disease","volume":"5","author":"Wright","year":"2015","journal-title":"Transl Psychiatry"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24012744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24012744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/molpharm.122.000606","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:32:02Z","timestamp":1739957522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24012744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0026895X24012744"],"URL":"https:\/\/doi.org\/10.1124\/molpharm.122.000606","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gait Abnormalities and Aberrant D2 Receptor Expression and Signaling in Mice Carrying the Human Pathogenic Mutation DRD2I212F","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/molpharm.122.000606","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"U.S. Government work not protected by U.S. copyright","name":"copyright","label":"Copyright"}]}}